Albinson Brock
Known title: SVP, Chief Accounting OfficerCIK: 0001636355
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADP Featured in Dividend and Peer Comparison Reports. Recent coverage highlights ADP as a stable dividend option and compares its performance against professional services peers. Analysts from TD Cowen included the company in a list of human capital management stocks to watch. The stock is currently trading near its 52-week high, with an average analyst target of $286.40.
Transaction History
| CTEV | ▲ Buy | Grant | 3,649 | $0 | 6/30/2026 | View on chart |
| CTEV | ▲ Buy | Grant | 2,956 | $0 | 3/31/2026 | View on chart |
| CTEV | ▲ Buy | Grant | 23,243 | $0 | 3/1/2026 | View on chart |
| CTEV | ▲ Buy | Grant | 1,169 | $0 | 12/31/2025 | View on chart |
| CTEV | ▲ Buy | Grant | 2,825 | $0 | 9/30/2025 | View on chart |
| ADP | ▼ Sell | Open Market | 1,170 | $292K | 3/1/2024 | View on chart |
| ADP | ▼ Sell | Open Market | 2,332 | $544K | 1/2/2024 | View on chart |
| ADP | ▼ Sell | Open Market | 1,598 | $406K | 9/5/2023 | View on chart |
| ADP | ▼ Sell | Open Market | 1,646 | $419K | 9/1/2023 | View on chart |
| ADP | ▼ Sell | Tax Withholding | 2,076 | $531K | 9/1/2023 | View on chart |
| ADP | ▼ Sell | Open Market | 2,424 | $618K | 9/1/2023 | View on chart |
| ADP | ▼ Sell | Open Market | 2,152 | $548K | 9/1/2023 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,424 | $336K | 9/1/2023 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,152 | $365K | 9/1/2023 | View on chart |
| ADP | ▲ Buy | Option Exercise | 1,646 | $340K | 9/1/2023 | View on chart |
| ADP | ▲ Buy | Grant | 738 | $0 | 9/1/2023 | View on chart |
| ADP | ▲ Buy | Grant | 5,146 | $0 | 8/3/2023 | View on chart |
| ADP | ▼ Sell | Open Market | 1,500 | $330K | 3/1/2023 | View on chart |
| ADP | ▼ Sell | Open Market | 1,173 | $288K | 9/2/2022 | View on chart |
| ADP | ▼ Sell | Tax Withholding | 1,223 | $301K | 9/1/2022 | View on chart |
| ADP | ▼ Sell | Open Market | 2,151 | $523K | 9/1/2022 | View on chart |
| ADP | ▼ Sell | Open Market | 2,424 | $589K | 9/1/2022 | View on chart |
| ADP | ▼ Sell | Open Market | 1,833 | $446K | 9/1/2022 | View on chart |
| ADP | ▼ Sell | Open Market | 1,646 | $400K | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Grant | 767 | $0 | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,424 | $336K | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,151 | $365K | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Option Exercise | 1,833 | $269K | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Option Exercise | 1,646 | $340K | 9/1/2022 | View on chart |
| ADP | ▲ Buy | Grant | 3,569 | $0 | 8/3/2022 | View on chart |
| ADP | ▼ Sell | Open Market | 2,534 | $521K | 9/2/2021 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,423 | $336K | 9/1/2021 | View on chart |
| ADP | ▲ Buy | Option Exercise | 1,929 | $207K | 9/1/2021 | View on chart |
| ADP | ▲ Buy | Option Exercise | 1,832 | $269K | 9/1/2021 | View on chart |
| ADP | ▼ Sell | Tax Withholding | 1,322 | $273K | 9/1/2021 | View on chart |
| ADP | ▼ Sell | Open Market | 1,929 | $400K | 9/1/2021 | View on chart |
| ADP | ▼ Sell | Open Market | 2,152 | $447K | 9/1/2021 | View on chart |
| ADP | ▼ Sell | Open Market | 2,423 | $503K | 9/1/2021 | View on chart |
| ADP | ▼ Sell | Open Market | 1,832 | $380K | 9/1/2021 | View on chart |
| ADP | ▲ Buy | Option Exercise | 2,152 | $365K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Claritev Selected by GDIT for WTC Health Program Support
Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.
Claritev Selected by GDIT for WTC Health Program Support. Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.